摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-3-氨基-3-(3-氯苯基)-丙酸 | 262429-49-2

中文名称
(R)-3-氨基-3-(3-氯苯基)-丙酸
中文别名
D-3-氨基-3-(3-氯苯基)丙酸;(R)-3-氨基-3-(3-氯苯基)丙酸
英文名称
(-)-(2R)-2-(3-chlorophenyl)-3-aminopropionic acid
英文别名
(R)-3-amino-3-(3-chloro-phenyl)-propionic acid;(R)-3-amino-3-(3-chlorophenyl)propanoic acid;(3R)-3-azaniumyl-3-(3-chlorophenyl)propanoate
(R)-3-氨基-3-(3-氯苯基)-丙酸化学式
CAS
262429-49-2
化学式
C9H10ClNO2
mdl
——
分子量
199.637
InChiKey
LIDRHPCWOYOBIZ-MRVPVSSYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    230-233 °C(Solv: water (7732-18-5); acetone (67-64-1))
  • 沸点:
    334.7±32.0 °C(Predicted)
  • 密度:
    1.333±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.3
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    63.3
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2922499990
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335

SDS

SDS:f0a653637a6fcf561f0eb5f1d5a57e73
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: (R)-3-Amino-3-(3-chloro-phenyl)-propionic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: (R)-3-Amino-3-(3-chloro-phenyl)-propionic acid
CAS number: 262429-49-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H10ClNO2
Molecular weight: 199.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    3-氨基-3-(3-氯苯基)丙酸 3-amino-3-(3-chlorophenyl)propanoic acid 68208-21-9 C9H10ClNO2 199.637
    —— (+/-)-4-(3-chlorophenyl)-2-azetidinone 930769-45-2 C9H8ClNO 181.622
    —— 3-(3-chlorophenyl)-3-(2-phenylacetamido)propanoic acid 262429-48-1 C17H16ClNO3 317.772

反应信息

  • 作为反应物:
    描述:
    (R)-3-氨基-3-(3-氯苯基)-丙酸氯化亚砜 作用下, 生成 (3R)-3-(3-chlorophenyl)-3-[(2,2,2-trifluoroacetyl)amino]propanoyl chloride
    参考文献:
    名称:
    Efficient synthesis of 2-aryl-6-methyl-2,3-dihydro-1H-pyridin-4-ones
    摘要:
    Syntheses of 2-aryl-6-methyl-2,3-dihydra-1H-pyridin-4-ones were achieved starting from corresponding beta-aryl-amino acids. This reaction sequence involved, as a key step, the condensation of an acid chloride with a diketone using SmI3 as catalyst. A final intramolecular cyclization furnished the attempted product. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(99)02164-4
  • 作为产物:
    描述:
    3-氯苯乙烯 在 CAL-B (lipase B from Candida antarctica) 、 作用下, 以 异丙醇甲苯 为溶剂, 反应 19.0h, 生成 (R)-3-氨基-3-(3-氯苯基)-丙酸
    参考文献:
    名称:
    通过脂酶催化β-内酰胺的对映选择性环裂解制备对映体纯的β-芳基取代的β-氨基酸和4-芳基取代的β-内酰胺的新途径
    摘要:
    开发了一种简单有效的直接酶法,用于通过CAL-B(南极假丝酵母的脂肪酶B )催化的对映选择性(E > 200)环合成4-芳基取代的β-内酰胺和相应的β-氨基酸对映体1当量裂解相应的外消旋β-内酰胺。60°C下i- Pr 2 O中的H 2 O含量。可以容易地分离出产物(R)-β-氨基酸(ee≥98%,产率≥42%)和未反应的(S)-β-内酰胺(ee≥95%,产率≥41%)。对映体β-内酰胺与18%HCl的开环得到相应的对映体纯β-氨基酸盐酸盐(ee≥99%)。
    DOI:
    10.1002/adsc.200505434
点击查看最新优质反应信息

文献信息

  • ENANTIOSELECTIVE ACYLATION OF β-PHENYLALANINE ACID AND ITS DERIVATIVES CATALYZED BY PENICILLIN G ACYLASE FROM<i>Alcaligenes faecalis</i>
    作者:Dengchao Li、Lilian Ji、Xinfeng Wang、Dongzhi Wei
    DOI:10.1080/10826068.2012.719847
    日期:2013.1.15
    This study developed a simple, efficient method for producing racemic β-phenylalanine acid (BPA) and its derivatives via the enantioselective acylation catalyzed by the penicillin G acylase from Alcaligenes faecalis (Af-PGA). When the reaction was run at 25°C and pH 10 in an aqueous medium containing phenylacetamide and BPA in a molar ratio of 2:1, 8 U/mL enzyme and 0.1 M BPA, the maximum BPA conversion
    这项研究开发了一种简单,有效的方法,该方法可通过粪便产碱杆菌(Af-PGA)中的青霉素G酰基转移酶催化对映选择性酰化来生产外消旋β-苯丙氨酸(BPA)及其衍生物。当反应在25:C和pH 10的水介质中以2:1摩尔比,8 U / mL酶和0.1 M的苯乙酰胺和BPA进行时BPA在40分钟时的最大BPA转化效率仅达到36.1%,但是,当pH值和苯乙酰胺与BPA的摩尔比分别提高到11和3:1时,BPA的最高转化效率提高到42.9%。在相对最佳的反应条件下,BPA衍生物的最大转化率在相对较短的反应时间(45-90分钟)内都达到了约50%。产物的对映体过量值(ee p )和底物的对映体过量值(ee s )均分别高于98%和95%。这些结果表明,本研究中建立的方法是实用,有效且对环境有益的,可用于对映体纯的BPA及其衍生物的工业生产。
  • Phenylalanine Aminomutase-Catalyzed Addition of Ammonia to Substituted Cinnamic Acids: a Route to Enantiopure α- and β-Amino Acids
    作者:Wiktor Szymanski、Bian Wu、Barbara Weiner、Stefaan de Wildeman、Ben L. Feringa、Dick B. Janssen
    DOI:10.1021/jo901833y
    日期:2009.12.4
    approach is described for the synthesis of aromatic α- and β-amino acids that uses phenylalanine aminomutase to catalyze a highly enantioselective addition of ammonia to substituted cinnamic acids. The reaction has a broad scope and yields substituted α- and β-phenylalanines with excellent enantiomeric excess. The regioselectivity of the conversion is determined by substituents present at the aromatic ring
    描述了一种合成芳香族α-和β-氨基酸的方法,该方法使用苯丙氨酸氨基变位酶催化氨向取代肉桂酸的高度对映选择性加成。该反应具有广泛的范围,并产生具有优异对映体过量的取代的α-和β-苯丙氨酸。转化的区域选择性由芳环上存在的取代基决定。提出了一种酶活性位点的盒模型,该模型由取代基的疏水性对酶对各种底物的亲和力的影响得出。
  • BICYCLIC-PYRIMIDINEDIONE COMPOUNDS
    申请人:MyoKardia, Inc.
    公开号:US20160176868A1
    公开(公告)日:2016-06-23
    The present invention provides novel bicyclic pyrimidinedione compounds that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds is described, as well as methods for treating HCM and other forms of heart disease.
    本发明提供了一种新颖的双环嘧啶二酮化合物,可用于治疗肥厚型心肌病(HCM)以及与左心室肥厚或舒张功能障碍相关的疾病。描述了这些化合物的合成和表征,以及治疗HCM和其他形式心脏疾病的方法。
  • [EN] BET BROMODOMAIN INHIBITORS AND THERAPEUTIC METHODS USING THE SAME<br/>[FR] INHIBITEURS DE BROMODOMAINES BET ET MÉTHODES THÉRAPEUTIQUES LES UTILISANT
    申请人:UNIV MICHIGAN
    公开号:WO2014164596A1
    公开(公告)日:2014-10-09
    Inhibitors of BET bromodomains and compositions containing the same are disclosed. Methods of using the BET bromodomain inhibitors in the treatment of diseases and conditions wherein inhibition of BET bromodomain provides a benefit, like cancers, also are disclosed.
    本文披露了BET bromodomain抑制剂及含有它们的组合物。还披露了使用BET bromodomain抑制剂治疗疾病和状况的方法,其中BET bromodomain的抑制提供益处,如癌症等疾病。
  • 3-Amino-3-arylpropionic acid n-alkyl esters, process for production thereof, and process for production of optically active 3-amino-3-arylpropionic acids and esters of the antipodes thereto
    申请人:Yamamoto Yasuhito
    公开号:US20060178433A1
    公开(公告)日:2006-08-10
    The present invention is to provide an n-alkyl 3-amino-3-arylpropionate represented by the formula (I): wherein Ar 1 represents an aryl group which may have a substituent(s), provided that a phenyl group and 4-methoxyphenyl group are excluded, R 1 represents an n-propyl group or an n-butyl group, and a process for preparing the same, and its optically active compound and an optically active (S or R)-3-amino-3-arylpropionic acid represented by the formula (III-a): wherein Ar represents an aryl group which may have a substituent(s), and * represents an asymmetric carbon, and a process for preparing an optically active n-alkyl (R or S)-3-amino-3-arylpropionate represented by the formula (IV-a): wherein Ar and R 1 have the same meanings as defined above, * represents an asymmetric carbon, provided that it has a reverse absolute configuration to the compound of the formula (III-a).
    本发明提供了一种n-烷基3-氨基-3-芳基丙酸酯,其化学式表示为(I):其中,Ar1表示一个芳基基团,可以具有一个或多个取代基,但不包括苯基和4-甲氧基苯基;R1表示一个n-丙基基团或n-丁基基团。本发明还提供了制备该化合物的方法,以及其光学活性化合物和光学活性(S或R)-3-氨基-3-芳基丙酸的化学式表示为(III-a):其中,Ar表示一个芳基基团,可以具有一个或多个取代基,*表示一个不对称碳,以及制备光学活性n-烷基(R或S)-3-氨基-3-芳基丙酸酯的方法,其化学式表示为(IV-a):其中,Ar和R1的含义与上述定义相同,*表示一个不对称碳,但其绝对构型与化合物的化学式(III-a)相反。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物